TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33064011

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Microdebrider‐assisted inferior turbinoplasty (MAIT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Patients without anterior septal deviation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Patients with anterior septal deviation
Number of subjects: 80
Study: 33596659

Group type: EXPERIMENTAL
Intervention: Nutritional educational intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 38
Study: 32416145

Group type: EXPERIMENTAL
Intervention: E2 75 mcg/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: E2 100 mcg/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: E2 200 mcg/day
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 2-day ring-free interval (substudy)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 4-day ring-free interval (substudy)
Number of subjects: 65
Study: 34991513

Group type: EXPERIMENTAL
Intervention: Cue-based feeding (BCBO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care feedings
Number of subjects: 60
Study: 33470769

Group type: EXPERIMENTAL
Intervention: Transdermal 17β‐estradiol (tE2, n = 21)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen (n = 19)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (n = 32)
Number of subjects: 72
Study: 35508300

Group type: EXPERIMENTAL
Intervention: Auricular point seed burying combined with fire dragon pot moxibustion
Number of subjects: 70

Group type: COMPARATOR
Intervention: Traditional Chinese medicine nursing intervention of burying seeds at auricular points (Control)
Number of subjects: 70
Study: 32546273

Group type: EXPERIMENTAL
Intervention: Adaptive designs (ADs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACE abstract checklist
Number of subjects: 0
Study: 34252286

Group type: EXPERIMENTAL
Intervention: 10 date fruits/day for 4 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal dietary intake without date fruit
Number of subjects: 48
Study: 33051309

Group type: EXPERIMENTAL
Intervention: Tech-supported model with video consultations
Number of subjects: 3533

Group type: COMPARATOR
Intervention: Standard model with routine home visits by nurses and physicians
Number of subjects: 3533
Study: 36081248

Group type: EXPERIMENTAL
Intervention: WBI + EMI
Number of subjects: 783

Group type: COMPARATOR
Intervention: WBI-only
Number of subjects: 783

Group type: COMPARATOR
Intervention: Assessment-only
Number of subjects: 783
Study: 36322258

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (daily, weekly, or monthly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weekly cholecalciferol supplementation
Number of subjects: 0
Study: 33200660

Group type: EXPERIMENTAL
Intervention: Reduced scanning parameters for DPT (60 kV, 3.2 mA) and LC (85 kV, 8 mA)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard scanning parameters as prescribed by the manufacturer
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Reduced scanning parameters for DPT and LC
Number of subjects: 38
Study: 33611729

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH)
Number of subjects: 17

Group type: COMPARATOR
Intervention: No therapeutic hypothermia (control group)
Number of subjects: 17
Study: 35618446

Group type: EXPERIMENTAL
Intervention: Whey protein shot (15 g of protein)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 18
Study: 34419058

Group type: EXPERIMENTAL
Intervention: Hybrid electric fields (EFs)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Ion current exposure
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: High relative humidity
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Low relative humidity
Number of subjects: 203
Study: 35420921

Group type: EXPERIMENTAL
Intervention: Enzalutamide plus ADT
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 1150
Study: 33486770

Group type: EXPERIMENTAL
Intervention: 3 mg/ml oligomer chitosan solution
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 6 mg/ml oligomer chitosan solution
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3 mg/ml 30 kDa chitosan solution
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 6 mg/ml 30 kDa chitosan solution
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.1% acetic acid
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.2% acetic acid
Number of subjects: 24

Group type: COMPARATOR
Intervention: Effervescent tablet (Polident)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine
Number of subjects: 24
Study: 33089454

Group type: EXPERIMENTAL
Intervention: Reverse Trendelenburg position (group RT)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Supine position (group S)
Number of subjects: 79
Study: 32013621

Group type: EXPERIMENTAL
Intervention: Experimental Occupational Therapy (EOT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Rehabilitation (SR)
Number of subjects: 0
Study: 37179154

Group type: EXPERIMENTAL
Intervention: Digital scanning
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional impression
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Copenhagen Index Score (CIS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: OHIP-14 scores
Number of subjects: 40
Study: 33948951

Group type: EXPERIMENTAL
Intervention: Novel scaffold treatment (n = 5)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Untreated control (n = 5)
Number of subjects: 5
Study: 32173950

Group type: EXPERIMENTAL
Intervention: Treatment Adherence Programme (TAP)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 183
Study: 36480798

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Plain old balloon angioplasty (POBA)
Number of subjects: 270

Group type: COMPARATOR
Intervention: DCB and POBA
Number of subjects: 270
Study: 34448111

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC) intervention (10 sessions) provided as a supplement to Early Head Start (EHS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group received home-based EHS plus 1 book per week for 10 weeks
Number of subjects: 0
Study: 35354455

Group type: EXPERIMENTAL
Intervention: Sodium fluoride + acetic acid (GFAA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium fluoride + gastric acid (GFGA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saliva (Gs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gastric acid (GGA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetic acid (GAA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vitabloc Mark II CAD (GFAA and GFGA)
Number of subjects: 40
Study: 32347768

Group type: EXPERIMENTAL
Intervention: Vaginal brachytherapy (VBT) for patients with disease confined to the uterus, >=50% myometrial invasion (MI) and/or grade 3 histology.
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (EBRT)+/‐VBT for patients with stage II disease, positive/close surgical margins or extra‐uterine extension.
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Stage IB - grade 3 and stage II in HR patients.
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Current risk grouping recommended by ESMO‐ESGO‐ESTRO.
Number of subjects: 683
Study: 32790718

Group type: EXPERIMENTAL
Intervention: Stepped-care (SC)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 128
Study: 33818277

Group type: EXPERIMENTAL
Intervention: On-axis measurements of axial length (AL) using Lenstar LS 900 biometer
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Off-axis measurements of axial length (AL) in paracentral positions (temporal, superior, inferior, nasal) using Lenstar LS 900 biometer
Number of subjects: 207

Group type: COMPARATOR
Intervention: Comparison of superior and nasal AL to central AL
Number of subjects: 207
Study: 34703055

Group type: EXPERIMENTAL
Intervention: Modified pectoral nerve block (30 ml of ropivacaine 0.2%)
Number of subjects: 50

Group type: COMPARATOR
Intervention: General anaesthesia (no block)
Number of subjects: 50
Study: 36137599

Group type: EXPERIMENTAL
Intervention: Best medical management (BMM) combined with endovascular therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best medical management (BMM) alone
Number of subjects: 0
Study: 35018550

Group type: EXPERIMENTAL
Intervention: Restricted means based approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parametric and nonparametric competitors
Number of subjects: 0
Study: 32747417

Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 34582624

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 32779223

Group type: EXPERIMENTAL
Intervention: Comprehensive Health Enhancement Support System information and support services (CHESS‐IS)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: CHESS with mentor
Number of subjects: 326

Group type: COMPARATOR
Intervention: Internet only
Number of subjects: 326
Study: 35805627

Group type: EXPERIMENTAL
Intervention: 5:2 Intermittent Fasting (IF)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Supervised Sprint Interval Training (SIT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combination of IF and SIT
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Exercise alone or with IF
Number of subjects: 34
Study: 34387258

Group type: EXPERIMENTAL
Intervention: Tape sealing of face masks
Number of subjects: 13

Group type: COMPARATOR
Intervention: No tape sealing (control)
Number of subjects: 13
Study: 34052947

Group type: EXPERIMENTAL
Intervention: Rebamipide
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Rebamipide (in patients with no Helicobacter pylori infection)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 33827457

Group type: EXPERIMENTAL
Intervention: Diffusional kurtosis imaging (DKI)
Number of subjects: 110
Study: 33186740

Group type: EXPERIMENTAL
Intervention: Taselisib (4 mg) plus fulvestrant (500 mg)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Placebo plus fulvestrant (500 mg)
Number of subjects: 516
Study: 32305272

Group type: EXPERIMENTAL
Intervention: BioFire FilmArray Blood Culture Identification (BCID) panel
Number of subjects: 100
Study: 36370124

Group type: EXPERIMENTAL
Intervention: Citalopram (add-on treatment)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo (control treatment)
Number of subjects: 95
Study: 33972742

Group type: EXPERIMENTAL
Intervention: tepotinib (500 mg once daily)
Number of subjects: 90

Group type: COMPARATOR
Intervention: sorafenib (400 mg twice daily)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: tepotinib
Number of subjects: 90

Group type: COMPARATOR
Intervention: sorafenib
Number of subjects: 90
Study: 32366288

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 128
Study: 33471486

Group type: EXPERIMENTAL
Intervention: Text message navigation (SMS)
Number of subjects: 1625

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1625
Study: 34003685

Group type: EXPERIMENTAL
Intervention: Smartphone-based application for monitoring blood pressure
Number of subjects: 7394

Group type: EXPERIMENTAL
Intervention: Intensive BP control group
Number of subjects: 7394

Group type: EXPERIMENTAL
Intervention: Standard BP control group
Number of subjects: 7394

Group type: EXPERIMENTAL
Intervention: Antihypertensive drug regimen change
Number of subjects: 7394

Group type: EXPERIMENTAL
Intervention: Monitoring BP via smartphone app
Number of subjects: 7394

Group type: EXPERIMENTAL
Intervention: Doctor monitoring of BP via app
Number of subjects: 7394
Study: 33206626

Group type: EXPERIMENTAL
Intervention: Soft silicone foam dressing
Number of subjects: 50
Study: 35379575

Group type: EXPERIMENTAL
Intervention: Combination of 1 g azithromycin orally on admission plus a third-generation cephalosporin intravenously for the first 48 hours, followed by amoxicillin 500 mg orally for another five days.
Number of subjects: 133

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 133
Study: 33325020

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen treatment (HBOT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hyperbaric air (HA)
Number of subjects: 24
Study: 35770525

Group type: EXPERIMENTAL
Intervention: Portable electronic bronchoscope (UE-EB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard bronchoscopy)
Number of subjects: 0
Study: 34131487

Group type: EXPERIMENTAL
Intervention: Family planning support intervention
Number of subjects: 317

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 317
Study: 32650729

Group type: EXPERIMENTAL
Intervention: Metronidazole followed by a commercial oral/vaginal probiotic
Number of subjects: 30

Group type: COMPARATOR
Intervention: Vaginal metronidazole alone
Number of subjects: 30
Study: 35768453

Group type: EXPERIMENTAL
Intervention: Resveratrol
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 34673771

Group type: COMPARATOR
Intervention: Methylphenidate (MPH) titrated based on weekly assessments, mean end-dose of 1.0 mg/kg/day
Number of subjects: 207

Group type: COMPARATOR
Intervention: Methylphenidate (MPH) titrated based on weekly assessments
Number of subjects: 207
Study: 32268472

Group type: EXPERIMENTAL
Intervention: 30‐min high‐intensity (80% HRmax; HIGH) cycling exercise
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 30‐min low‐intensity (50% HRmax; LOW) cycling exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: 30‐min seated rest (CONTROL)
Number of subjects: 13
Study: 35769160

Group type: EXPERIMENTAL
Intervention: High-dose Bojungikgi-Tang (BJIGT)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Standard-dose Bojungikgi-Tang (BJIGT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 105
Study: 32217365

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 104
Study: 34562774

Group type: EXPERIMENTAL
Intervention: Bougie-guided technique
Number of subjects: 23

Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 23
Study: 33094359

Group type: EXPERIMENTAL
Intervention: Metastatic cancer patients
Number of subjects: 80275

Group type: EXPERIMENTAL
Intervention: Emergency surgery performed on metastatic cancer patients
Number of subjects: 80275

Group type: EXPERIMENTAL
Intervention: Dyspnea at rest/moderate exertion
Number of subjects: 80275
Study: 35654863

Group type: EXPERIMENTAL
Intervention: Peloid therapy + home exercise
Number of subjects: 90

Group type: COMPARATOR
Intervention: Paraffin therapy + home exercise
Number of subjects: 90
Study: 33157048

Group type: EXPERIMENTAL
Intervention: Atezolizumab + Bevacizumab
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Checkpoint blockade
Number of subjects: 823

Group type: COMPARATOR
Intervention: Angiogenesis blockade
Number of subjects: 823
Study: 33454354

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy (WBC) at cryogenic temperatures (−110 °C till −160 °C), n = 33
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy (WBC)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo-controlled group (CG), n = 29
Number of subjects: 62
Study: 33984886

Group type: EXPERIMENTAL
Intervention: Levodopa‐carbidopa intestinal gel (LCIG) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 0
Study: 36045304

Group type: EXPERIMENTAL
Intervention: TLPLDC vaccine
Number of subjects: 144

Group type: COMPARATOR
Intervention: TLPLDC + G
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 34936271

Group type: EXPERIMENTAL
Intervention: Tongyuan acupuncture combined with medication
Number of subjects: 74

Group type: COMPARATOR
Intervention: Medication alone (estradiol valerate tablets, 2 mg per day from the fifth day of menstruation)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 74
Study: 32989542

Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI)
Number of subjects: 138

Group type: COMPARATOR
Intervention: White light endoscopy (WLE)
Number of subjects: 138
Study: 32452814

Group type: EXPERIMENTAL
Intervention: Personal Health Network (PHN) app with care coordination
Number of subjects: 27

Group type: COMPARATOR
Intervention: Care coordination alone
Number of subjects: 27
Study: 36339240

Group type: EXPERIMENTAL
Intervention: Baduanjin intervention (60 min × 5 times/week, 8 weeks)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Baduanjin combined with low-carbohydrates diet (8 weeks)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: All groups (BA, LC, CON)
Number of subjects: 54
Study: 32973192

Group type: EXPERIMENTAL
Intervention: VRN-based 3D CNN
Number of subjects: 2124

Group type: COMPARATOR
Intervention: Clinical experts (orthopedists)
Number of subjects: 2124
Study: 34135179

Group type: EXPERIMENTAL
Intervention: Antenatal care assessment
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Postnatal care assessment
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Immunization
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Overall health service delivery score
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Service provision score
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Facility assessment score
Number of subjects: 17
Study: 32783645

Group type: EXPERIMENTAL
Intervention: Focused Attention (FA) meditation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mobile Neurofeedback (mNF) meditation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Combined FA and mNF data
Number of subjects: 20
Study: 35377724

Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 0
Study: 33817768

Group type: EXPERIMENTAL
Intervention: eHealth education interventions (synchronous, asynchronous, hybrid)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Asynchronous eHealth education intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hybrid eHealth education intervention
Number of subjects: 24
Study: 36194181

Group type: EXPERIMENTAL
Intervention: AB-506 at 160 mg daily for 28 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: AB-506 at 400 mg daily for 28 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: AB-506 at 400 mg daily for 28 days in Asian HS
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: AB-506
Number of subjects: 28
Study: 33814258

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Number of subjects: 30
Study: 34983475

Group type: EXPERIMENTAL
Intervention: Bilateral central lymph node dissection (BCND)
Number of subjects: 581

Group type: COMPARATOR
Intervention: Ipsilateral central lymph node dissection (ICND)
Number of subjects: 581
Study: 33980505

Group type: EXPERIMENTAL
Intervention: Mitomycin C augmented trabeculectomy
Number of subjects: 453

Group type: COMPARATOR
Intervention: Escalating medical management with intraocular pressure reducing drops
Number of subjects: 453
Study: 32898838

Group type: EXPERIMENTAL
Intervention: Ethanol, alcohol-based hand sanitizers, povidone-iodine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactoferrin, ethanol, hydroxychloroquine, quaternary ammonium compounds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon-alpha, lactoferrin, hydroxychloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypothiocyanite, N-chlorotaurine, povidone-iodine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quaternary ammonium compounds, hydroxychloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quaternary ammonium compounds, alcohol-based nasal antiseptics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N-chlorotaurine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other products (not specified)
Number of subjects: 0
Study: 33162314

Group type: EXPERIMENTAL
Intervention: Back massage (15 minutes daily for four days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study: 32603618

Group type: EXPERIMENTAL
Intervention: Older hearing-impaired (OHI) listeners
Number of subjects: 20

Group type: COMPARATOR
Intervention: Older normal-hearing (ONH) listeners
Number of subjects: 20
Study: 34537121

Group type: EXPERIMENTAL
Intervention: Transversus Abdominis Plane Block (TAPB)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Spinal anesthesia alone (Control)
Number of subjects: 63
Study: 32472902

Group type: EXPERIMENTAL
Intervention: Prehospital plasma (two units) followed by standard care fluid resuscitation
Number of subjects: 501

Group type: COMPARATOR
Intervention: Standard care (crystalloid)
Number of subjects: 501
Study: 33307377

Group type: EXPERIMENTAL
Intervention: Nurse practitioner-delivered brief intervention (NBI)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Computer-delivered brief intervention (CBI)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Assessment-only cohort (historical comparison group)
Number of subjects: 300
Study: 32893505

Group type: EXPERIMENTAL
Intervention: Increased loop diuretic dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination diuretic therapy (loop diuretic plus chlorothiazide)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard loop diuretic therapy
Number of subjects: 0
Study: 36190613

Group type: EXPERIMENTAL
Intervention: Morphological traits analysis among eggplant genotypes
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: SSR markers analysis
Number of subjects: 17
Study: 33849584

Group type: EXPERIMENTAL
Intervention: Immediate skin-to-skin contact (SSC)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Early skin-to-skin contact (SSC)
Number of subjects: 297